Pathophysiology
Type 2 DM involves insulin resistance in peripheral tissues, progressive beta-cell dysfunction, increased hepatic glucose output, and incretin deficiency.
Diagnosis Criteria
- Fasting glucose >= 126 mg/dL
- 2h post-glucose >= 200 mg/dL (OGTT)
- HbA1c >= 6.5%
- Random glucose >= 200 mg/dL with symptoms
Stepwise Drug Cascade
- Metformin (1st line) — reduces hepatic gluconeogenesis
- Metformin + SGLT2i or GLP-1 RA (2nd line) — add based on CV/renal risk
- Metformin + SGLT2i + GLP-1 RA (3rd line)
- Add insulin if HbA1c remains >7.5%
Complications
Microvascular: Retinopathy, Nephropathy, Neuropathy. Macrovascular: MI, Stroke, PVD.
Special Situations
Pregnancy: Insulin only (oral agents contraindicated). Surgery: Switch to insulin peri-operatively.
References & further reading
Every clinical claim in this article is anchored to a primary source. Click through to verify, and use the same habit in your revision.
Revision history
- 19 September 2026 — Initial publication
Frequently asked questions
What is the first-line drug for Type 2 Diabetes?
Metformin is first-line unless contraindicated. It reduces hepatic gluconeogenesis and improves peripheral insulin sensitivity. Start at 500mg daily, titrate to 2000mg/day.
What is the HbA1c target for most patients?
Individualized: <7% for most adults. <6.5% if achievable without hypoglycemia. <8% may be appropriate for older adults with comorbidities.
Which drug class has cardiovascular benefits?
GLP-1 receptor agonists (semaglutide, liraglutide) and SGLT2 inhibitors (empagliflozin, dapagliflozin) have proven cardiovascular and renal benefits in major trials (LEADER, EMPA-REG, DECLARE).
Related reading
Hand this plan to your study group.
CrackCMS is a free study desk for medical PG aspirants — 3,300+ PYQs, full mock simulators, spaced-repetition flashcards and an AI tutor that compares stem formats across UPSC CMS and NEET PG.
CrackCMS by CrackLabs AI · Editorial policy · Medical review policy
Join the discussion
Comments are opening soon.
The CrackCMS blog uses GitHub Discussions for comments (no spam, no third-party trackers). The discussion forum is being set up and comments will appear here automatically once it's live.
In the meantime, ping us at crackwith.ai@gmail.com or use the in-app AI tutor for any clarification.
